Mammary Tumor Virus Antigen: Sensitive Immunoassay
Louis R. Sibal 1,
William F. Feller 2,
Mary Alexander Fink 3,
Barbara E. Kohler 3,
William T. Hall 3, and
Howard E. Bond 3
1 National Cancer Institute, Bethesda, Maryland 20014
2 Georgetown University Hospital, School of Medicine, Washington, D.C. 20007
3 National Cancer Institute
A rapid, sensitive immuno-assay for mammary tumor virus antigen based on inhibition of passive hemagglutination has been developed. The method permits measurement of this antigen in mouse milk from which the fat has been removed.